Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Cancer Treatment Reviews
|
January 23, 2026
Insights into RAS-driven melanoma and its therapeutic implications
Eftychia Chatziioannou, Konstantinos Lallas, Tobias Sinnberg, et al.
Cell Death & Disease
|
September 13, 2018
Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugs
Elena Makino, Vanessa Gutmann, Corinna Kosnopfel, et al.
Cancers
|
December 9, 2023
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma
Heike Niessner, Anna Hüsch, Corinna Kosnopfel, et al.
Cancer Research Communications
|
September 7, 2023
PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction <i>In Vitro</i> and <i>In Vivo</i>
Lisa Marie Fröhlich, Heike Niessner, Birgit Sauer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 2019
Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma
Teresa M S Amaral, Marie-Christine Hoffmann, Tobias Sinnberg, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Ecto-NOX Disulfide-Thiol Exchanger 2 (ENOX2/tNOX) Is a Potential Prognostic Marker in Primary Malignant Melanoma and May Serve as a Therapeutic Target
Matti Böcker, Eftychia Chatziioannou, Heike Niessner, et al.
Pigment Cell & Melanoma Research
|
June 27, 2015
PTEN regulates IGF-1R-mediated therapy resistance in melanoma
Jun Wang, Tobias Sinnberg, Heike Niessner, et al.
International Journal of Cancer
|
February 11, 2012
Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells
Sarah Schott, Heike Niessner, Tobias Sinnberg, et al.
Nutrients
|
August 10, 2021
Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model
Annie Lauer, Markus Burkard, Heike Niessner, et al.
Oncotarget
|
April 19, 2017
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Cancer Treatment Reviews
|
January 23, 2026
Insights into RAS-driven melanoma and its therapeutic implications
Eftychia Chatziioannou, Konstantinos Lallas, Tobias Sinnberg, et al.
Cell Death & Disease
|
September 13, 2018
Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugs
Elena Makino, Vanessa Gutmann, Corinna Kosnopfel, et al.
Cancers
|
December 9, 2023
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma
Heike Niessner, Anna Hüsch, Corinna Kosnopfel, et al.
Cancer Research Communications
|
September 7, 2023
PARP Inhibitors Effectively Reduce MAPK Inhibitor Resistant Melanoma Cell Growth and Synergize with MAPK Inhibitors through a Synthetic Lethal Interaction <i>In Vitro</i> and <i>In Vivo</i>
Lisa Marie Fröhlich, Heike Niessner, Birgit Sauer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 16, 2019
Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma
Teresa M S Amaral, Marie-Christine Hoffmann, Tobias Sinnberg, et al.
International Journal of Molecular Sciences
|
November 9, 2024
Ecto-NOX Disulfide-Thiol Exchanger 2 (ENOX2/tNOX) Is a Potential Prognostic Marker in Primary Malignant Melanoma and May Serve as a Therapeutic Target
Matti Böcker, Eftychia Chatziioannou, Heike Niessner, et al.
Pigment Cell & Melanoma Research
|
June 27, 2015
PTEN regulates IGF-1R-mediated therapy resistance in melanoma
Jun Wang, Tobias Sinnberg, Heike Niessner, et al.
International Journal of Cancer
|
February 11, 2012
Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells
Sarah Schott, Heike Niessner, Tobias Sinnberg, et al.
Nutrients
|
August 10, 2021
Ex Vivo Evaluation of the Sepsis Triple Therapy High-Dose Vitamin C in Combination with Vitamin B1 and Hydrocortisone in a Human Peripheral Blood Mononuclear Cells (PBMCs) Model
Annie Lauer, Markus Burkard, Heike Niessner, et al.
Oncotarget
|
April 19, 2017
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinase
Corinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.
Page
of 6